Belinostat 98.0%(HPLC)
98.0%(HPLC)
Properties
| Assay Purity | >98%(HPLC) |
| M pt. | 160℃(dec.) |
Safety Information
| Hazard Statement(s) | H340 - H361f - H373 |
| Precautionary Statement | P201 - P202 - P260 - P280 - P308 + P313 - P405 |
| Symbol |
|
| Signal word | Danger |
| Storage Temp. | Store at room temperature.. |
| Packaging | Glass Bottle |
Description
Recommended products
6-Methyl-2-(P-Tolylamino)-4H-31-Benzoxazin-4-One 95.0%(HPLC)
Purpose
For R&D use onlynot for drug household or other uses.
General Description
Belinostat (trade name Beleodaq previously known as PXD101) is a histone deacetylase inhibitor drug developed by TopoTarget for the treatment of hematological malignancies and solid tumors.
Documents
| SDS |
| COA |
| Specification |
| Bulk quote order form |